Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
ADILAdial Pharmaceuticals, Inc.
Filed Nov 14, 2018 · 10-Q · 45 days after period end · 0001213900-18-015559
| Metric | Q3 2018 | Q3 2017 |
|---|---|---|
| Net Income | -$8.19M | -$292.63K |
| EPS Diluted | -$1.48 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adial Pharmaceuticals, Inc. · CIK 1513525 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end
